Weekly Intelligence · 4 articles
Vet Industry Intel: Jan 18 – Jan 24, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Regulatory & Policy (3)
Products & Technology (1)
Regulatory & Policy
Jan 20, 2026 [9/10] fda_cvm
FDA approves first drug to delay the onset of congestive heart failure in dogs - Boehringer Ingelheim
The FDA has approved the first drug by Boehringer Ingelheim to delay the onset of congestive heart failure in dogs.
FDA · Boehringer Ingelheim
Jan 21, 2026 [8/10] fda_cvm
FDA grants full approval for canine idiopathic epilepsy medication - DVM360
The FDA has granted full approval to a medication used to treat canine idiopathic epilepsy.
FDA · DVM360
Jan 22, 2026 [7/10] fda_cvm
nixiFLOR Injection Approved by the FDA for Bovine Respiratory Disease Treatment - Bovine Veterinarian
The FDA has approved nixiFLOR Injection for the treatment of bovine respiratory disease, as reported by Bovine Veterinarian.
FDA · Bovine Veterinarian
Products & Technology
Jan 23, 2026 [7/10] fda_cvm
FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease - DVM360
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for the treatment of bovine respiratory disease.
FDA · DVM360